PDCD1 and hepatocellular carcinoma: Expression of PD-1/PD-L1 in HCC have been described in 17% (PD-L1) and 27% (PD-1) on immune and 10–20% (PD-L1) on tumor cells, using immunohistochemistry [40,41,75,76,77].